TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun

Ying Li(Third Hospital of Hebei Medical University), Shengqing Li(Fudan University)
Oncotarget
January 6, 2016
Cited by 46


Related Papers